Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FTC To Testify On Generic Reform; Agency Report May Be “Months” Away

Apr 22 2002

• By The Pink Sheet

Related Content

Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch

Apr 22 2002

GPhA Seeks Coalitions To Balance PhRMA: Big Business, Unions, Insurers

Apr 15 2002

AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others

Aug 13 2001

Buspirone Generic Approvals Expected By End Of February After Patent Ruling

Feb 25 2002

Biovail Says Tiazac Andrx Settlement “Satisfies” FTC; Patent Remains Listed

Feb 25 2002

“Orange Book” Listings Are Not Immune From Antitrust Scrutiny, FTC Says

Jan 14 2002

Generic Drug Competition Hearing Planned For Senate Commerce Committee

Mar 18 2002

AHP K-Dur Settlement With FTC Applies To Brand And Generic Divisions

Feb 25 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window